Detalhe da pesquisa
1.
BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors.
Mol Cancer
; 22(1): 110, 2023 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37443114
2.
Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: A proof-of-concept study.
Int J Cancer
; 147(1): 277-284, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31953839
3.
Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways.
Transl Oncol
; 40: 101878, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38183801
4.
Screening for epidermal growth factor receptor mutations in lung cancer.
N Engl J Med
; 361(10): 958-67, 2009 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-19692684
5.
Multiplex Analysis of CircRNAs from Plasma Extracellular Vesicle-Enriched Samples for the Detection of Early-Stage Non-Small Cell Lung Cancer.
Pharmaceutics
; 14(10)2022 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36297470
6.
mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients.
J Transl Med
; 9: 163, 2011 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21951562
7.
Anti-epidermal growth factor vaccine antibodies increase the antitumor activity of kinase inhibitors in ALK and RET rearranged lung cancer cells.
Transl Oncol
; 14(1): 100887, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33129112
8.
Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells.
NPJ Precis Oncol
; 5(1): 65, 2021 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34267282
9.
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.
J Transl Med
; 8: 135, 2010 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-21167064
10.
IL-6/gp130/STAT3 signaling axis in cancer and the presence of in-frame gp130 somatic deletions in inflammatory hepatocellular tumors.
Future Oncol
; 5(3): 305-8, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19374537
11.
Characterising acquired resistance to erlotinib in non-small cell lung cancer patients.
Expert Rev Respir Med
; 13(10): 1019-1028, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31411906
12.
AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy.
Nat Commun
; 10(1): 1812, 2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31000705
13.
Prospective analysis of liquid biopsies of advanced non-small cell lung cancer patients after progression to targeted therapies using GeneReader NGS platform.
Transl Cancer Res
; 8(Suppl 1): S3-S15, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35117060
14.
Anti-Epidermal Growth Factor Vaccine Antibodies Enhance the Efficacy of Tyrosine Kinase Inhibitors and Delay the Emergence of Resistance in EGFR Mutant Lung Cancer Cells.
J Thorac Oncol
; 13(9): 1324-1337, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29751136
15.
Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.
Sci Rep
; 13(1): 3620, 2023 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869103
16.
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer.
Nat Commun
; 8(1): 410, 2017 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28871105
17.
Liquid Biopsy in Non-Small Cell Lung Cancer.
Front Med (Lausanne)
; 3: 69, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28066769
18.
cfDNA analysis from blood in melanoma.
Ann Transl Med
; 3(20): 309, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26697469
19.
BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors.
Melanoma Res
; 25(6): 486-95, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26366702
20.
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.
Sci Rep
; 5: 17499, 2015 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26639561